Press Releases

Distributed: April 23, 2009

Alerts Login

Share on StockTwits  
Melbourne, April 23, 2009 (ABN Newswire) - Biota Holdings Limited (ASX:BTA)(PINK:BTAHY) today announced that it had received notification from GlaxoSmithKline (LON:GSK) that Relenza sales were A$462 million and indicative royalties were A$32.3 million, for the three months ended 31 March 2009.

Indicative royalties for the nine months to 31 March 2009 total A$36.1 million.

Biota CEO Peter Cook attributed the performance to recent significant orders for pandemic stockpiling from the UK and Japanese Governments.


Share on StockTwits  


About Biota Holdings Limited

Biota is a leading anti-infective drug development company based in Melbourne Australia, with key expertise in respiratory diseases, particularly influenza. Biota developed the first-in-class neuraminidase inhibitor, zanamivir, subsequently marketed by GlaxoSmithKline as Relenza.

Biota research breakthroughs have included a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease, licensed to AstraZeneca and novel nucleoside analogues designed to treat hepatitis C virus (HCV) infections, licensed to Boehringer Ingelheim. Biota has clinical trials underway with its lead compound for human rhinovirus (HRV) infection in patients with compromised respiration or immune systems. In addition, Biota has a key partnership with Daiichi-Sankyo for the development of second generation influenza antivirals.

Relenza(TM) is a registered trademark of the GlaxoSmithKline group of companies. *Further information available at http://www.biota.com.au

Contact

Investor / Analyst Enquiries
Biota Holdings Limited
Peter Cook
Tel: +61-3-9915-3720

Damian Lismore
Tel: +61-3-9915-3721


  Related Companies

>>>         Biota Holdings Limited
>>>        GlaxoSmithKline plc

  Related Industry Topics:

Biotech | Drugs & OTC | Health & Pharm General | 

  This Page Viewed:  (Last 7 Days: 13) (Last 30 Days: 54) (Since Published: 6444) 

   

  ABN Newswire on Social Media

Site Search

 
 ENGLISH   All Languages
Send A Press Release
Connecting Investors with Opportunity

Upcoming Webcasts

Mr Glen Darby
Condor Blanco Mines
Monday, April 28, 2014

Mr Tim Mckinnon
Madison Resources Group
Monday, April 28, 2014

Mr Greg Starr MD
Crater Gold
Monday, April 28, 2014

Mr Allan Kelly MD
Doray Minerals
Monday, April 28, 2014

Mr Christopher Darby MD & CEO
Valence Industries
Monday, June 09, 2014


Webcast Your Annual General Meeting

Mobile Video TV

qrcode
Scan with your Mobile Phone to view ABN Newswire Video Channel on Mobile
 
City Index - A Better Way To Trade